Furthermore, CGRP levels were significantly reduced in subjects who responded to sumatriptan treatment after an NO2-induced migraine, while there was no significant reduction in CGRP levels in sumatriptan non-responders [39]. The gene discussed is CALCA; the disease is migraine disorder.